Guides
What the human research shows and where the rules stand, one compound or question at a time. Every claim links to its source, and each guide says when it was last checked.
- SafetyReviewed November 1, 2026
How to give a subcutaneous injection from a vial
Drawing from a vial and injecting under the skin with a U-100 insulin syringe, one step at a time, with your own dose and a to-scale look at where the needle ends up.
Read the guide · 7 sources - RegulationReviewed November 1, 2026
Compounded semaglutide and tirzepatide: where things stand
The drug shortages that opened the door to compounded semaglutide and tirzepatide ended in 2024 and 2025. What that means for pharmacies, why FDA keeps warning about dosing errors and salt forms, and what is still undecided.
Read the guide · 19 sources - Compound guideReviewed November 1, 2026
Growth hormone secretagogues: what the human trials show, and what to watch
MK-677, ipamorelin, GHRP-2, GHRP-6, hexarelin, CJC-1295 and tesamorelin all push the body to release more growth hormone. Only tesamorelin is FDA-approved. What the human studies measured, the side effects they recorded, and what they never tested.
Read the guide · 30 sources
These guides are education, not medical advice: they give no doses and promise no results. Dose ranges and the reconstitution math live in the peptide database. Spotted an error or a newer source? ask@peptidehelp.com